The shareholders of medical equipment manufacturer Mindray Medical International will vote next month on a management buyout offer that would take the company private.
A general meeting of shareholders will be held in Hong Kong on February 26. The management group would pay $28 per ordinary share or American Depository Share in cash in a transaction that values the company at approximately $3.3 billion on a fully diluted basis, according to a revised offer from November 4, 2015.
When the transaction is complete, the company will be owned by Li Xiting, Mindray's executive chairman, president, and co-CEO; Xu Hang, chairman of the board of directors; and Cheng Minghe, co-CEO and chief strategic officer.
